PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.61%
Revenue growth above 1.5x QCOM's 0.04%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
11.90%
Positive gross profit growth while QCOM is negative. John Neff would see a clear operational edge over the competitor.
22.28%
Positive EBIT growth while QCOM is negative. John Neff might see a substantial edge in operational management.
24.52%
Positive operating income growth while QCOM is negative. John Neff might view this as a competitive edge in operations.
20.85%
Positive net income growth while QCOM is negative. John Neff might see a big relative performance advantage.
20.33%
Positive EPS growth while QCOM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
20.49%
Positive diluted EPS growth while QCOM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.11%
Slight or no buybacks while QCOM is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.11%
Diluted share reduction more than 1.5x QCOM's 0.35%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
0.06%
Dividend growth under 50% of QCOM's 6.13%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
10.25%
Positive OCF growth while QCOM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-17.95%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
37.66%
10Y revenue/share CAGR under 50% of QCOM's 108.13%. Michael Burry would suspect a lasting competitive disadvantage.
12.73%
5Y revenue/share CAGR above 1.5x QCOM's 6.31%. David Dodd would look for consistent product or market expansions fueling outperformance.
-9.62%
Negative 3Y CAGR while QCOM stands at 17.90%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
45.40%
10Y OCF/share CAGR at 50-75% of QCOM's 72.19%. Martin Whitman might fear a structural deficiency in operational efficiency.
-10.96%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-27.88%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
91.44%
Net income/share CAGR above 1.5x QCOM's 43.46% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-2.12%
Negative 5Y net income/share CAGR while QCOM is 8.04%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-29.28%
Negative 3Y CAGR while QCOM is 6.26%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
91.46%
Positive growth while QCOM is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
96.82%
Below 50% of QCOM's 392.45%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
43.67%
Below 50% of QCOM's 205.21%. Michael Burry suspects a serious short-term disadvantage in building book value.
332.01%
10Y dividend/share CAGR above 1.5x QCOM's 102.71%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
68.60%
5Y dividend/share CAGR above 1.5x QCOM's 37.07%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
27.39%
3Y dividend/share CAGR similar to QCOM's 25.17%. Walter Schloss finds parallel short-term dividend strategies for both companies.
8.83%
Our AR growth while QCOM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
4.63%
We show growth while QCOM is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.78%
Positive asset growth while QCOM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.20%
Under 50% of QCOM's 0.91%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
4.92%
We have some new debt while QCOM reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-1.20%
Our R&D shrinks while QCOM invests at 1.03%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.96%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.